Literature DB >> 31588776

Short Communication: Carotid Intima-Media Thickness Is Not Associated with Neurocognitive Impairment Among People Older than 50 Years With and Without HIV Infection from Thailand.

Akarin Hiransuthikul1,2,3, Aurauma Chutinet3,4, Salila Sakulrak1, Jitlada Samajarn3,4, Pongpat Vongsayan3,4, Naruchorn Kijpaisalratana3,4, Wasan Akarathanawat3,4, Tanakorn Apornpong1, Aroonsiri Sangarlangkarn1, Sivaporn Gatechompol1,5, Win Min Han1, Pairoj Chattranukulchai6, Stephen Kerr1,7, Kiat Ruxrungtham1,2, Anchalee Avihingsanon1,5.   

Abstract

Neurocognitive impairment (NCI) contributes to poor quality of life among HIV-positive individuals. Cardiovascular risk factors, including the predictor of subclinical atherosclerosis, carotid intima-media thickness (cIMT), are reported to be associated with NCI. Data on NCI and its association with cIMT among HIV positive are limited, especially in Asian populations. We aimed to determine the prevalence of NCI and its association with cIMT among HIV-positive and HIV-negative aging Thai individuals. Cognitive performance was evaluated by the Thai version of Montreal Cognitive Assessment (MoCA) with a cutoff of <25/30 for diagnosis of NCI. Depression was evaluated by PHQ-9 Patient Depression Questionnaire, with scores ≥5 indicating depression. cIMT measurement was performed by experienced neurologists, and abnormal cIMT was defined as cIMT ≥0.9 mm or presence of carotid plaques. Among 340 well suppressed and aging HIV-positive and 102 HIV-negative matched participants, the median age (interquartile range) was 55 (52-59) years and 61.5% were males. For HIV positive group, the median duration on antiretroviral therapy was 18.3 years with median CD4 of 615.5 cells/mm3, and 97.4% had current plasma HIV RNA <50 copies/mL. The most common antiretroviral agents used were tenofovir disoproxil fumarate (76.8%), lamivudine (70.3%), efavirenz (26.7%), and emtricitabine (23.8%). HIV-positive and HIV-negative participants performed comparably between each domain and had comparable prevalence of NCI (59.4% vs. 61.7%, p = .69). However, the HIV-positive group had a high prevalence of depression (24.71% vs. 13.73%, p = .019). HIV-positive status [adjusted odd ratio (aOR) 0.91; 95% confidence interval (CI) 0.57-1.47, p = .71] and cIMT (aOR 1.17; 95% CI 0.77-1.79, p = .47) were not significantly associated with NCI. Given the high prevalence of NCI and depression among aging HIV-positive individuals, routine screening for NCI and depression should be integrated into the HIV care services.

Entities:  

Keywords:  HIV; aging; carotid intima-media thickness; neurocognitive

Year:  2019        PMID: 31588776     DOI: 10.1089/AID.2019.0139

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  2 in total

Review 1.  Trends and Clinical Characteristics of HIV and Cerebrovascular Disease in Low- and Middle-Income Countries (LMICs) Between 1990 and 2021.

Authors:  George Ransley; Stanley Zimba; Yohane Gadama; Deanna Saylor; Laura Benjamin
Journal:  Curr HIV/AIDS Rep       Date:  2022-10-20       Impact factor: 5.495

2.  Neurocognitive performance and quality of life of older adults with HIV on antiretroviral treatment in Northern Thailand.

Authors:  Linda Aurpibul; Patumrat Sripan; Arunrat Tangmunkongvorakul; Wilawan Chaikan; Saowalak Sarachai; Kriengkrai Srithanaviboonchai
Journal:  J Int AIDS Soc       Date:  2022-09       Impact factor: 6.707

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.